LOGO
  • ABOUT US
      ABOUT US
    • What We Provide
    • Why We Are Different
    • Senior Management
    • How to Contact Us
  • TRANSACTIONS
      TRANSACTIONS
    • Chemical
    • Life Science
  • NEWS & ARTICLES
      NEWS & ARTICLES
    • 2019
    • 2018
    • 2017
    • 2016
    • 2015
    • 2014
    • 2013
    • 2012
    • 2011
    • 2010
    • 2009
  • CONFERENCES
      CONFERENCES
    • Chemical
    • Life Science
  • INDUSTRY PORTALS
      INDUSTRY PORTALS
    • Chemicals
    • Medical Devices
    • Pharmaceuticals & Biotech
  • INTERNET PRESENTATIONS
      INTERNET PRESENTATIONS
    • Live & Scheduled
    • Archived

News and Articles - 2017

2017 2016 2015 2014 2013 2012 2011 2010 2009
  • Chemical M&A and IPOs - A Warped View - Young & Partners (ICIS Chemical Business Nov. 10 - 16, 2017 issue)Amid talk of a hot M&A market and IPOs, if you take a hard look at the numbers, reality is different
  • Pharma and Biotech Markets (Young & Partners article in Pharma Executive eBook) Sept 2017Young & Partners examines the biopharma stock market and M&A trends and their implications
  • The Highs, Lows and the Unexpected - Young & Partners (ICIS Chemical Business Sept 8 - 14, 2017 issue) Young & Partners' observations about chemical industry's stock market performance and financings (debt and equity)
  • Fire and Ice - Chemical Mergers and Acquisitions- Young & Partners (ICIS Chemical Business Sept 1 -7, 2017 issue)While the M&A dollar volume is hot, a look behind the numbers shows that not everything is, or will be
  • Peter Young - Chemical Heritage Foundation Bolte Award (2017)Chemical Heritage to give the Richard J. Bolte Sr. Award to Peter Young of Young & Partners on Heritage Day
  • Calm Before The Storm - Young & Partners (ICIS Chemical Business May 19 - 25, 2017 issue)First Quarter M&A volume was modest, but we are heading for a monster year in M&A in terms of dollar volume
  • Pharma and Biotech Markets - Mostly Sunny, But An Uncertain Forecast (Pharmaceutical Executive May 9, 2017) Peter Young offers a summary of the strategic, stock market, M&A and financing issues facing the biopharma industry
  • In M&A, Now You See It, Now You Don't - Young & Partners ICIS Chemical Business Feb 24, 2017 issue)Young & Partners presents its contrarian analysis of what happened last year in global M&A and the outlook.
  • Chemical Financing Hits Record Levels - Young & Partners (ICIS Chemical Business Feb 17, 2017 Issue)Young & Partners analyzes the record dollar value of debt and equity financing in chemicals
  • Pharma and Biotech Markets - Challenges and Opportunities (Pharma Exec January 2017 Issue)Peter Young examines what is happening in the M&A and Equity Financing Markets and the Implications for Management
HOME   |   CONTACT US   |   DISCLAIMER YOUNG & PARTNERS LLC   |   535 Fifth Avenue, 4th Floor, New York, New York 10017   |   212-682-5555